Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Expert Opinion on Emerging Drugs
|
April 26, 2012
Emerging drugs for major depressive disorder: an update
Sakina J Rizvi, Sidney H Kennedy
Journal of Psychiatry & Neuroscience : JPN
|
August 27, 2013
Management strategies for SSRI-induced sexual dysfunction
Sakina J Rizvi, Sidney H Kennedy
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 20, 2011
The keys to improving depression outcomes
Sakina J Rizvi, Sidney H Kennedy
Expert Opinion on Emerging Drugs
|
July 30, 2009
Emerging drugs for major depressive disorder
Sidney H Kennedy, Sakina J Rizvi
CNS Drugs
|
March 3, 2010
Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness
Sidney H Kennedy, Sakina J Rizvi
Current Psychiatry Reports
|
March 10, 2018
Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions
Sakina J Rizvi, Clare Lambert, Sidney Kennedy
Neuroscience and Biobehavioral Reviews
|
May 5, 2021
Reward processing as a common diathesis for chronic pain and depression
Sakina J Rizvi, Wiebke Gandhi, Tim Salomons
Current Topics in Behavioral Neurosciences
|
April 18, 2022
Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders
Shijing Wang, Francesco Leri, Sakina J Rizvi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 25, 2021
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
Shijing Wang, Francesco Leri, Sakina J Rizvi
Advances in Experimental Medicine and Biology
|
April 26, 2026
From Neural Circuits to Behavior: Examining the Central Role of Anhedonia in Major Depression
Leen K Ghanayem, Poornima Kumar, Sakina J Rizvi
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Expert Opinion on Emerging Drugs
|
April 26, 2012
Emerging drugs for major depressive disorder: an update
Sakina J Rizvi, Sidney H Kennedy
Journal of Psychiatry & Neuroscience : JPN
|
August 27, 2013
Management strategies for SSRI-induced sexual dysfunction
Sakina J Rizvi, Sidney H Kennedy
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 20, 2011
The keys to improving depression outcomes
Sakina J Rizvi, Sidney H Kennedy
Expert Opinion on Emerging Drugs
|
July 30, 2009
Emerging drugs for major depressive disorder
Sidney H Kennedy, Sakina J Rizvi
CNS Drugs
|
March 3, 2010
Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness
Sidney H Kennedy, Sakina J Rizvi
Current Psychiatry Reports
|
March 10, 2018
Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions
Sakina J Rizvi, Clare Lambert, Sidney Kennedy
Neuroscience and Biobehavioral Reviews
|
May 5, 2021
Reward processing as a common diathesis for chronic pain and depression
Sakina J Rizvi, Wiebke Gandhi, Tim Salomons
Current Topics in Behavioral Neurosciences
|
April 18, 2022
Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders
Shijing Wang, Francesco Leri, Sakina J Rizvi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 25, 2021
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
Shijing Wang, Francesco Leri, Sakina J Rizvi
Advances in Experimental Medicine and Biology
|
April 26, 2026
From Neural Circuits to Behavior: Examining the Central Role of Anhedonia in Major Depression
Leen K Ghanayem, Poornima Kumar, Sakina J Rizvi
Page
of 7